Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Seoul National University Hospital
Seoul National University Hospital
Thomas Jefferson University
Thomas Jefferson University
HonorHealth Research Institute
Albert Einstein College of Medicine
University of Birmingham
Roswell Park Cancer Institute
University of Chicago
University of Nebraska
Virginia Commonwealth University
Massachusetts General Hospital
Washington University School of Medicine
Dana-Farber Cancer Institute
Washington University School of Medicine
University of Alabama at Birmingham
Mayo Clinic
Children's Hospital Medical Center, Cincinnati
University of Georgia
Montefiore Medical Center
Cedars-Sinai Medical Center
Children's Hospital Medical Center, Cincinnati
The Methodist Hospital Research Institute
Emory University
University of Rochester
Dana-Farber Cancer Institute
Weill Medical College of Cornell University
Beth Israel Deaconess Medical Center
University of Southern California
H. Lee Moffitt Cancer Center and Research Institute
Stanford University
St. Jude Children's Research Hospital
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Imperial College London
Memorial Sloan Kettering Cancer Center
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Maryland, Baltimore
Institut Cancerologie de l'Ouest
Medical College of Wisconsin
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Cedars-Sinai Medical Center
Kaiser Permanente
Roswell Park Cancer Institute
Massachusetts General Hospital
Centre Francois Baclesse
Institut Cancerologie de l'Ouest